Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Signed in as:
filler@godaddy.com
Michael Betel, President and Founder of the Fatty Liver Alliance and Marko Korenjak, President of ELPA - European Liver Patients' Association introduce the First Annual NAFLD and NASH Primary Care Summit.
This is part 1 of the First Annual NAFLD and NASH Primary Care Summit event.
Introduction by Dr. Bertrand Leboucher and featuring Dr. Naim Alkhouri as he presents "NAFLD and NASH Defined" in about 20 minutes. Learn more about what NAFLD is and the spectrum of disease, including NASH.
This is part 2 of the First Annual NAFLD and NASH Primary Care Summit event.
What are the NAFLD and NASH Knowledge gaps? What do we need to know? Dr. Giada Sebastiani shares her insights in her presentation (20 min).
This is part 3 of the First Annual NAFLD and NASH Primary Care Summit event.
What are the clinical assessment tools available today to identify patients most at risk of having NAFLD and progressing to more serious liver disease (NASH)? Watch Dr. Mazen Noureddin, MD, MHSc, Hepatologist, share the latest. "Finally we are in touch with Primary Care Physicians online."
This is part 4 of the First Annual NAFLD and NASH Primary Care Summit event.
Are Primary Care Physicians ready for the world of NAFLD and NASH? Dr. Noah Ivers shares the perspectives of a Primary Care Physician and how they perceive the future of fatty liver disease and the real world changes needed.
This is part 5 of the First Annual NAFLD and NASH Primary Care Summit event.
Dr. Ming Jung is a Family Practice Physician and this is her presentation from the First Annual NAFLD and NASH Primary Care Summit - How to tailor care for your Primary Care patients who have fatty liver disease.
This is part 6 of the First Annual NAFLD and NASH Primary Care Summit event.
There is an incredible need for interdisciplinary relationships to ensure the best of patient care for NAFLD and NASH. This is an excellent presentation by Dr. Mark Swain, Hepatologist. Part 7 from the First Annual NAFLD and NASH Primary Care Summit.
This is part 7 of the First Annual NAFLD and NASH Primary Care Summit event.
Dr. Manal Abdalmalek presents, "Are Lifestyle Modifications Enough"? With no approved pharmacological treatments for NASH, can lifestyle modification impact fatty liver disease?
This is part 8 of the First Annual NAFLD and NASH Primary Care Summit event.
NAFLD/NASH and the relationship to Type-2 Diabetes, Obesity & Cardiovascular Risk with Dr. Scott Isaacs, Endocrinologist.
This is part 9 of the First Annual NAFLD and NASH Primary Care Summit event.
Risk-Stratification of Fibrosis Among Non-Alcoholic Fatty Liver Disease (NAFLD) Patients by Dr. Abdel-Aziz Shaheen.
This is part 10 of the First Annual NAFLD and NASH Primary Care Summit event.
Dr. Kris Kowdley,from Liver Institute Northwest shares an update on new innovations in NAFLD and NASH. A really great overview of what happens to the liver with NASH, and how the disease progresses.
How do each of the new therapies work? Which treatments are modifiers of NAFLD? What are the goals of NASH treatment? What is a weight loss pyramid? Which drug treatments work best to improve fibrosis?
This is part 11 of the First Annual NAFLD and NASH Primary Care Summit event.
Jeff McIntyre from the Global Liver Institute and Heather Watson have a great conversation about how patients are impacted by NAFLD and NASH.
This is part 12 of the First Annual NAFLD and NASH Primary Care Summit event.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.